Wilmer Cutler Pickering Hale and Dorr has advised Veralto Corporation. Latham & Watkins has advised the underwriters. Veralto Corporation has announced the pricing of a $725...
Veralto Prices $725 Million Senior Notes Due 2032
Danaher Corporation Completes €3 Billion Senior Notes Offering
WilmerHale has advised Danaher Corporation. Latham & Watkins has advised the underwriters. Danaher Corporation (NYSE: DHR) (“Danaher”) has completed an offering of euro-denominated senior notes with...
Blackstone to Acquire Champions Group from Odyssey Investment Partners
Weil, Gotshal & Manges has advised Blackstone. Latham & Watkins LLP has advised Odyssey Investment Partners. Blackstone, through its funds managed by Blackstone’s perpetual private equity...
Precision BioSciences Announces $75 Million Registered Direct Offering
Latham & Watkins LLP has advised Precision BioSciences, Inc. Mintz has advised Guggenheim Securities, as the sole book-running manager. Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage...
KKR and Apollo Announce $3 Billion Convertible Preferred Stock Investment in Keurig Dr Pepper
Kirkland & Ellis has advised KKR. Latham & Watkins has advised Apollo. Paul, Weiss, Rifkind, Wharton & Garrison LLP has advised Keurig Dr Pepper. Global investment...
BC Partners’ Sale of Majority Stake in GardaWorld
Simpson Thacher & Bartlett is representing Garda World Security Corporation (“GardaWorld”), Founder, Chairman and CEO Stephan Crétier, and GardaWorld management, while Latham & Watkins acted as...
Rocket Pharmaceuticals’ $175 Million Public Offering
K&L Gates advised Rocket, and Latham advised underwriters. Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) announced the pricing of an underwritten public offering of 7,812,500 shares of its common...
Acumen’s $130 Million Common Stock Public Offering
Ropes & Gray advised Acumen, and Latham & Watkins advised the underwriters. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) announced the pricing of an upsized underwritten public offering of...
Zentalis Pharmaceuticals’ $250 Million Underwritten Offering of Common Stock
Latham & Watkins represented Zentalis in the offering, and Cooley represented the underwriters. Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL) announced the pricing of an underwritten offering of...
Amgen’s $24 Billion Senior Notes Offering
Latham & Watkins advised Amgen, and Shearman & Sterling advised the underwriters. Amgen Inc. priced an offering of $24.0 billion aggregate principal amount of senior notes,...
Vor Biopharma’s $115.8 Million Common Stock Offering and Private Placement
Latham & Watkins LLP represented the underwriters and placements agents in the transaction. Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced...
VillageMD’s $8.9 Billion Acquisition of Summit Health-CityMD
Latham & Watkins represented VillageMD in the transaction, Cleary Gottlieb and McDermott Will & Emery represented Summit Health-CityMD, while Wachtell, Lipton, Rosen & Katz served as legal...